JJBC
James J. Burns & Company’s Akebia Therapeutics AKBA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.8K | Hold |
11,748
| – | – | 0.01% | 155 |
|
|
2025
Q1 | $22.6K | Sell |
11,748
-754
| -6% | -$1.45K | ﹤0.01% | 143 |
|
|
2024
Q4 | $24K | Sell |
12,502
-3,100
| -20% | -$5.95K | ﹤0.01% | 147 |
|
|
2024
Q3 | $21K | Hold |
15,602
| – | – | ﹤0.01% | 141 |
|
|
2024
Q2 | $16K | Hold |
15,602
| – | – | ﹤0.01% | 128 |
|
|
2024
Q1 | $25K | Sell |
15,602
-2,800
| -15% | -$4.49K | 0.01% | 85 |
|
|
2023
Q4 | $23K | Sell |
18,402
-6,140
| -25% | -$7.67K | 0.01% | 120 |
|
|
2023
Q3 | $28K | Sell |
24,542
-600
| -2% | -$685 | 0.01% | 104 |
|
|
2023
Q2 | $23K | Hold |
25,142
| – | – | 0.01% | 113 |
|
|
2023
Q1 | $14K | Hold |
25,142
| – | – | ﹤0.01% | 112 |
|
|
2022
Q4 | $15K | Hold |
25,142
| – | – | 0.01% | 79 |
|
|
2022
Q3 | $8K | Buy |
+25,142
| New | +$8K | ﹤0.01% | 79 |
|